362 related articles for article (PubMed ID: 19028028)
1. Metabolic activity of probiotics-oxalate degradation.
Murphy C; Murphy S; O'Brien F; O'Donoghue M; Boileau T; Sunvold G; Reinhart G; Kiely B; Shanahan F; O'Mahony L
Vet Microbiol; 2009 Apr; 136(1-2):100-7. PubMed ID: 19028028
[TBL] [Abstract][Full Text] [Related]
2. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
Abratt VR; Reid SJ
Adv Appl Microbiol; 2010; 72():63-87. PubMed ID: 20602988
[TBL] [Abstract][Full Text] [Related]
3. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans?
Mogna L; Pane M; Nicola S; Raiteri E
J Clin Gastroenterol; 2014; 48 Suppl 1():S91-5. PubMed ID: 25291139
[TBL] [Abstract][Full Text] [Related]
4. Oxalate degradation by intestinal lactic acid bacteria in dogs and cats.
Weese JS; Weese HE; Yuricek L; Rousseau J
Vet Microbiol; 2004 Jul; 101(3):161-6. PubMed ID: 15223120
[TBL] [Abstract][Full Text] [Related]
5. Effect of a Probiotic Supplement Containing Lactobacillus Acidophilus and Bifidobacterium Animalis Lactis on Urine Oxalate in Calcium Stone Formers with Hyperoxaluria: A Randomized, Placebo-controlled, Double-blind and In-vitro Trial.
Tavasoli S; Jalali S; Naji M; Borumandnia N; Shakiba Majd G; Basiri A; Khosravi Darani K; Karamad D; Tajabadi-Ebrahimi M; Taheri M
Urol J; 2021 Jun; 19(3):179-188. PubMed ID: 34129232
[TBL] [Abstract][Full Text] [Related]
6. Portrait of a canine probiotic Bifidobacterium--from gut to gut.
O'Mahony D; Murphy KB; MacSharry J; Boileau T; Sunvold G; Reinhart G; Kiely B; Shanahan F; O'Mahony L
Vet Microbiol; 2009 Oct; 139(1-2):106-12. PubMed ID: 19523775
[TBL] [Abstract][Full Text] [Related]
7. A dynamic model that simulates the human upper gastrointestinal tract for the study of probiotics.
Mainville I; Arcand Y; Farnworth ER
Int J Food Microbiol; 2005 Apr; 99(3):287-96. PubMed ID: 15808363
[TBL] [Abstract][Full Text] [Related]
8. In vitro anti-inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria.
Giardina S; Scilironi C; Michelotti A; Samuele A; Borella F; Daglia M; Marzatico F
J Food Sci; 2014 Mar; 79(3):M384-90. PubMed ID: 24471378
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
[TBL] [Abstract][Full Text] [Related]
10. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.
Saarela M; Maukonen J; von Wright A; Vilpponen-Salmela T; Patterson AJ; Scott KP; Hämynen H; Mättö J
Int J Antimicrob Agents; 2007 Mar; 29(3):271-80. PubMed ID: 17207972
[TBL] [Abstract][Full Text] [Related]
11. Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus.
Turroni S; Vitali B; Bendazzoli C; Candela M; Gotti R; Federici F; Pirovano F; Brigidi P
J Appl Microbiol; 2007 Nov; 103(5):1600-9. PubMed ID: 17953571
[TBL] [Abstract][Full Text] [Related]
12. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
[TBL] [Abstract][Full Text] [Related]
13. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
[TBL] [Abstract][Full Text] [Related]
14. Effect of a Lactobacillus animalis strain on composition and metabolism of the intestinal microflora in adult dogs.
Biagi G; Cipollini I; Pompei A; Zaghini G; Matteuzzi D
Vet Microbiol; 2007 Sep; 124(1-2):160-5. PubMed ID: 17462835
[TBL] [Abstract][Full Text] [Related]
15. Assessment of in vitro oxalate degradation by Lactobacillus species cultured from veterinary probiotics.
Cho JG; Gebhart CJ; Furrow E; Lulich JP
Am J Vet Res; 2015 Sep; 76(9):801-6. PubMed ID: 26309108
[TBL] [Abstract][Full Text] [Related]
16. Identification and evaluation of the probiotic potential of lactobacilli isolated from canine milk.
Martín R; Olivares M; Pérez M; Xaus J; Torre C; Fernández L; Rodríguez JM
Vet J; 2010 Aug; 185(2):193-8. PubMed ID: 19451012
[TBL] [Abstract][Full Text] [Related]
17. [Together strong: probiotics to promote health in people and animals].
Timmerman HM
Tijdschr Diergeneeskd; 2006 Oct; 131(19):697-700. PubMed ID: 17052077
[No Abstract] [Full Text] [Related]
18. Lactobacillus gasseri Gasser AM63(T) degrades oxalate in a multistage continuous culture simulator of the human colonic microbiota.
Lewanika TR; Reid SJ; Abratt VR; Macfarlane GT; Macfarlane S
FEMS Microbiol Ecol; 2007 Jul; 61(1):110-20. PubMed ID: 17506826
[TBL] [Abstract][Full Text] [Related]
19. Potential Role of Lactobacillus and Bifidobacterium for Preventing Kidney Stones.
Masoleh AM; Khoshnood S; Haddadi MH; Rostamzad A; Narki M; Hoshmandfar R; Sadeghifard N
Clin Lab; 2023 May; 69(5):. PubMed ID: 37145061
[TBL] [Abstract][Full Text] [Related]
20. Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability.
Abe F; Muto M; Yaeshima T; Iwatsuki K; Aihara H; Ohashi Y; Fujisawa T
Anaerobe; 2010 Apr; 16(2):131-6. PubMed ID: 19638311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
